Your Expert Speakers: Drug Developers, Academics & Associations

Chris Abbosh

Principal Clinical Fellow, AstraZeneca Clinical Fellowship

University College London

Christopher Conn

Director, Companion Diagnostics Strategy Lead

AbbVie

Charles Koyias

Associate Director, Global Medical Affairs, Oncology

AbbVie

Tom Defay

Deputy Head, Diagnostics Strategy & Development

Alexion Pharmaceuticals, Inc.

Janelle Schrag

Assistant Director, Research Programs

Association of Community Cancer Centers

Zisis Kozlakidis

Head of Laboratory Services and Biobanking

International Agency for Research on Cancer/World Health Organization (IARC/WHO)

Chowdary Dondapati

Executive Director, Head of CDx Marketing (US)

Bayer Oncology

Michael Kiebish

Chief Precision Medicine Officer

BERG

Chris Whelan

Associate Director & Head of Translational Genetics

Biogen

Krystin Meidell

Director, Global Regulatory Strategy

AbbVie

Kashyap Patel

President

Community Oncology

Antonella Cardone

Executive Director

European Cancer Patient Coalition

Alessandra Cesano

Chief Medical Officer

ESSA Pharma

Mark Stewart

Vice President, Science Policy

Friends of Cancer Research

Roman Yelensky

Executive Vice President & Chief Technology Officer

Gristone Bio

Jaya Krishnan

Co-Founder

Genome Biologics

Christine Blinco

Global Director of Marketing, Oncology Diagnostics

GlaxoSmithKline

Ellie Corigliano

Head of CDx Cell & Gene Therapies Oncology

GlaxoSmithKline

Stephane Wong

Immuno-Oncology Companion Diagnostics Senior Director

GlaxoSmithKline

Matt Davis

Director of NGS

Gritstone Bio

Don Bergstrom

Executive Vice President and Head of Research & Development

Relay Therapeutics

Anne-Marie Martin

Senior Vice President , Global Head of Experimental Medicine

GlaxoSmithKline

Roni Mamluk

Chief Executive Officer

Ayala Pharmaceuticals

John Ferbas

Director, Department of Medical Sciences

Amgen

Tim Heffernan

Executive Director, Oncology Research

MD Anderson Cancer Center- Translational Research to Advance Therapeutics & Innovation in Oncology

Evi Lianidou

Professor of Analytical Chemistry, Clinical Chemistry; Head, Laboratory of Analytical Chemistry, ACTC Lab

University of Athens

Eugean Jiwanmall

Senior Research Analyst for Medical Policy & Technology Evaluation

Independence Blue Cross

Andrea Stevens

Global CoDx Market Access Director

Janssen Inc.

Johan Baeck

Senior Vice President Clinical Development & Medical Affairs

Jounce Therapeutics

Nikki Martin

Director, Precision Medicine Initiatives

LUNGevity

Sri Venkatram

Director, CDx Strategy

AbbVie

Travis Hollman

Dermatopathologist Memorial Sloan

Kettering Cancer Center

Jennifer Dacpano- Komansky

Director, Global Regulatory Affairs, Medical Devices

Novartis

Diane Da Silva

Associate Director of Translational Medicine

Parker Institute for Cancer Immunotherapy

Jörg Engelbergs

Scientific-Regulatory Expert Targeted & Personalized Biomedicines

Paul-Ehrlich-Institut Federal Institute for Vaccines and Biomedicines

Danielle Murphy

Director, Translational Oncology

Pfizer

Markus Zettl

Senior Director of Immuno–Oncology

Pieris Pharmaceuticals GmbH

Shane Olwill

Senior Vice President, Head of Translational Science

Pieris Pharmaceuticals GmbH

Ming Sound Tsao

Professor & Senior Scientist

Princess Margaret Cancer Centre, University Health Network

Brian Baker

Senior Director, Regulatory Affairs (CDx)

Regeneron Pharmaceuticals

Javier Perez

Director, Precision Medicine, Companion Diagnostics

Regeneron Pharmaceuticals

Kristina McGuire

Sr. Director and Head of CDx & Lab Operations

Regeneron

Katherine Block

Director, Biomarker Sciences

Sangamo Therapeutics

David Portman

Chief Executive Officer, Chief Medical Officer

Sermonix Pharmaceuticals

Gary Riordan

CDx Regulatory Consultant

Sermonix Pharmaceuticals

Theresa Whiteside

Professor of Pathology, Immunology and Otolaryngology

UPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute

Arunthi Thiagalingam

Director, Pharmacology/ Translational Medicine

Spectrum Pharmaceuticals

Qing Kang-Fortner

Associate Director - Translational Medicine

Syros Pharmaceuticals

Michael Fossel

President & Founder

Telocyte

James Hewitt

IVD Product Expert

TÜV SÜD

Kaye Foster

Senior Advisor & Executive Coach

The Boston Consulting Group (BCG)

Jeanine Roodhart

Oncology Specialist

UMC Utrecht

Michele Vendruscolo

Chief Scientific Officer

University of Cambridge & Wren Therapeutics

Steven Berman

Science Policy Analyst

US Food & Drug Administration

Joshua Xu

Branch Chief, National Center for Toxicological Research

US Food & Drug Administration

Your Expert Speakers: Diagnostic & Technology Developers

Courtney Nicholson

Director Business Development

Abcam

Kate Knobil

Chief Medical Officer

Agilent Technologies

Gavin Gordon

Vice President, Clinical Market Development

Akoya Biosciences

Jude O’Donnell

Head, Regulatory Strategy

Almac Diagnostic Services

Charles Mathews

Principal

ClearView Healthcare Partners

Shirin Hasan

Associate Vice President, Head of Global Clinical Affairs

Agilent Technologies

Trevor Page

Chief Business Officer, Companion Diagnostics

Agilent Technologies

Matthew Pink

Director, Business Development

Biodesix

Norbert Farkas

Founder & Managing Partner

Centivis

Tom Li

Head of Global Biopharma Business Development

Burning Rock Biotech

Mark Kiel

Co-Founder & Chief Science Officer

Genomenon

Daniel Simon

Senior Vice President, Biopharma Business Development

Guardant Health

Andrea Schütte

Director, Liquid Biopsy Biobank

Indivumed, GmbH

Greg Jones

Senior Director of Medical Affairs

Inivata

Jess Lambe

Director of CDx Partnering

Illumina

Tim Forshew

Head of Science and Innovation & Co-Founder

Inivata

Katherine T Landschulz, PhD

Therapeutic Area Lead, Biomarker Solution Center

Labcorp Technology

William Powell

Director Product Technology and Strategy

Leica Biosystems

Qingyan Au

Principal Scientist, Director of Multiplexing Operations, Pharma

NeoGenomics Laboratories

Nicolas Garreau de Loubresse

Director of Business Development

Nuprobe

Andrew Beck

Co-Founder & Chief Executive Officer

Path AI

Dawn McHugh

Senior Director Strategic Business Development

Personalis

Erin Newburn

Director, Field Application Scientist

Personalis

Alan Wookey

Companion Diagnostics & Oncology Scientific Advisor

Q2 Solutions

Kaye Foster

Senior Advisor & Executive Coach

The Boston Consulting Group (BCG)

Mark Li

Chief Executive Officer

Resolution Bioscience

Christoph Majewski

Lifecycle Leader CDx

Roche Diagnostics

Marc Yoskowitz

Executive Vice President & Chief Strategy Officer, Life Sciences

Tempus Labs

Angel Rodriguez

Medical Director

Natera Oncology

Dennis O’Malley

Senior Pathologist

NeoGenomics Laboratories

John Simmons

Global Vice President, Biopharma Business Development

Natera

Luca Quagliata

Vice President, Global Head of Medical Affairs

Thermo Fisher Scientific

Brian Kelly

Vice President Global Biopharma and CDx Strategy

Caris Life Sciences

Nicholas Confuorto

Senior Director, Digital Spatial Profiling Business Unit, Global Marketing

NanoString

Scott Bornheimer

Associate Director Medical & Scientific Affairs

BD Biosciences

Steve Anderson

Chief Scientific Officer

LabCorp Drug Development

Robert McCormack

Independent

Keith Wharton

Vice President, Medical Director

Ultivue